Brad Gray talked to the Puget Sound Business Journal about how honing in on cancer diagnostics has already started to pay dividends. Seattle biotech NanoString Technologies (Nasdaq: NSTG) is finding ...
10x Genomics has begun commercial shipments of a new 5,000–plex gene expression panel that increases plex by an order of magnitude over previous panels, a month after announcing the launch of the ...
PLEASANTON, Calif., May 17, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has won an injunction in its patent litigation ...
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a peer-reviewed paper ...
Bruker has formed a new, single division out of the various spatial biology assets it has acquired over the years. Now under a single operational banner, it includes the company’s previous Bruker ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The acquisition marks the close ...
A company with roots in developing tools for translational research has raised $15.3 million to execute the first step of its pursuit of market share in diagnostics. When it was granted the CE Mark in ...
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced that it has closed its asset acquisition of the business of NanoString Technologies, Inc., headquartered in Seattle ...
Seattle's NanoString Technologies ($NSTG) stands to make up to $45 million if it can come up with a successful companion diagnostic test to screen for a subset of ...
In an order posted to the site of the U.S. District Court for the District of Delaware, the court stated: “10x Genomics (TXG), Inc. and Prognosys Biosciences, Inc. sued NanoString Technologies, Inc.1 ...
A little more than two months ago, NanoString Technologies filed for bankruptcy – weary from having to pay $31 million to 10X Genomics after losing a patent infringement lawsuit. Today is a different ...
* Nanostring technologies-under terms of deal, lam will provide up to $50 million of funding intended to cover costs of development and regulatory approval * Nanostring technologies inc - lam will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results